GlassScriptPhysician profile
Emad Y Mousa
NPI 1003070194
$10,760.71
in general payments reported to CMS, 2019-2025
18 companies · $46.29 in 2025
The $46.29 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $32.21 · 2021: $9,847 · 2022: $320 · 2023: $196 · 2024: $188 · 2025: $46.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,814.30 | 2021 | |
| Conmed Corporation | $155.14 | 2022-2023 | Airseal |
| Shield Therapeutics INC | $154.65 | 2023-2024 | Accrufer |
| Hologic Sales and Service, LLC | $133.09 | 2019-2024 | Novasure, Myosure Tissue Removal Device, Aptima |
| Astrazeneca Pharmaceuticals LP | $128.40 | 2022 | |
| Axonics, INC. | $71.51 | 2022 | |
| Astellas Pharma US INC | $61.36 | 2023-2025 | Veozah |
| Indivior INC. | $41.22 | 2019 | |
| Minerva Surgical, INC | $33.13 | 2019 | |
| Sage Therapeutics, LLC | $30.95 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $29.28 | 2022 | |
| Abbvie INC. | $18.57 | 2019 | |
| Merck Sharp & Dohme LLC | $18.10 | 2019 | |
| Myovant Sciences INC. | $17.89 | 2021 | |
| Pfizer INC. | $16.04 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $14.57 | 2021 | |
| Baxter Healthcare | $11.64 | 2022 | |
| Organon LLC | $10.87 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emad Mousa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.